Microsoft word - pil-ya460 au_e04_final 20120914.doc
FERRUM H® Iron Polymaltose
Consumer Medicine Information
What is in this leaflet This leaflet answers some of the common questions about FERRUM H. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of using FERRUM H against the benefits this medicine is expected to have for you. If you have any concerns about this medicine, ask your doctor or pharmacist.
Keep this leaflet with your medicine. You may need to read it again. What FERRUM H is used for FERRUM H provides a source of iron that can help to replenish a shortage of iron in patients with iron deficiency. FERRUM H is used when dosage by mouth is impractical or contraindicated and when disturbances in the gastrointestinal tract make absorption difficult or uncertain. Before you are given FERRUM H When you must not be given it Do not use FERRUM H if:
• You are known to be sensitive (allergic) to any of the ingredients of FERRUM H
• Your anaemia is not due to a shortage of iron
• You have a condition known as haemochromatosis (an excess of iron in the body)
• You have any medical conditions or health problems including arthritis, bronchial asthma,
• You are in the 1st trimester of a pregnancy
FERRUM H should not be used after the expiry date printed on the label.
Consumer Medicine Information Ferrum H
If you are not sure whether you should be given FERRUM H please talk to your doctor.
Before you are given it You should be aware that:
• A blood test should have been carried out to ensure treatment with this medicine is
• If you have a history of asthma, eczema or other atopic allergies you are more susceptible to
You must tell your doctor if:
• You or a blood relative have the condition haemochromatosis
• You have a history ofliver disease
If you have not told your doctor about any of the above, please do so before you are given FERRUM H.
Taking other medicines
Tell your doctor if you are taking any other medicines, including any that you buy without a prescription from a pharmacy, supermarket or health food shop. Some medicines may interfere with FERRUM H. These include:
• Drugs that are used to treat heart disease and high blood pressure known as ACE inhibitors
(e.g. captopril, enalapril, fosinopril, lisinopril or quinalapril)
Your doctor or pharmacist has more information on medicines to avoid while taking FERRUM H.
How FERRUM H is given FERRUM H is given in a prescribed manner into the muscle. The injection technique is well defined and must be adhered to.
Failure to inject as recommended could result in persistent staining of the skin.
FERRUM H should never be injected into the arm or other exposed areas.
Your doctor has detailed information on the correct injection technique.
Before receiving your first dose, you should receive a small "test dose" which may help reduce the chance of a serious reaction occurring.
Your doctor will decide what dose and how long you will receive FERRUM H.
Consumer Medicine Information Ferrum H
If you are given too much (overdose)
As FERRUM H is given to you under the supervision of your doctor, it is very unlikely that you will be given an overdose. However, if you experience several side effects, tell your doctor immediately. The symptoms of an overdose may include the side effects listed in the side effects section but are usually of a more severe nature. Side Effects Tell your doctor, nurse or pharmacist if you do not feel well while you are using FERRUM H. FERRUM H helps most people with low iron levels but it may have unwanted side effects in a few people. All medicines can have side effects. Sometimes they are serious, most of the time they are not. Ask your doctor to answer any question you may have.
Side effects that have been reported by people using FERRUM H include:
• Flushing, sweating, chills and fever • Chest and back pain • Pain at site of injection • Local redness or swelling at the injection site • Abdominal pain • Nausea, vomiting • Headache, dizziness • Joint and muscle pains • Sensation of stiffening of the arms, legs or face • Fainting • Hypotension • Difficulty in breathing • Rash
Adverse reactions can be delayed by 1-2 days after treatment with FERRUM H. Incorrect injection technique could result in staining of the skin. Do not be alarmed by this list of possible side effects. You may not experience any of them. Other side effects not listed above may also occur in some patients. Tell your doctor if you notice any other effects.
Consumer Medicine Information Ferrum H After using Ferrum H Storage
FERRUM H will be stored in the pharmacy or on the ward.
The ampoules should be stored below 25°C in the original cartons. The product should not be frozen. Protect from light. Once the ampoules have been opened they should be used immediately. FERRUM H is to be kept out of the reach and sight of children.
Product Description What it looks like
FERRUM H comes in a glass ampoule containing 2 mL of solution. The product is supplied in cardboard boxes each containing 5 ampoules. Ingredients
Active ingredient:
• Water for injections • Sodium hydroxide • Hydrochloric acid
Medicine classification Prescription Only Medicine Sponsor
FERRUM H is supplied in Australia by: Vifor Pharma Pty Ltd Level 8, 80 Dorcas Street South Bank, Melbourne VIC 3006 Australia Exclusive New Zealand distributor: Pharmacy Retailing (NZ) Limited trading as Healthcare Logistics Auckland, New Zealand Consumer Medicine Information Ferrum H
Australian Registration Number AUST R 68110 This leaflet was prepared in September 2012.
LACK OF SLEEP Asist. univ. Gabriela LICA MIHAILA We don't know what sleep is. We do know we need it to survive. Many organs in the body canrest and recover during relaxed wakefulness -- to a similar extent to that achieved during sleep -- butthe cerebral cortex seems unable to do this," said Jim Horne director of the Sleep Research Laboratoryat the Sough borough University in Leicestersh
(Joint work with Yoni Nazarathy, ex Swinburn Univ Tech)(and Johan van Leeuwaarden, Eurandom and Eindhoven TU)YN’s August 2010 seminar2011 QUESTA ‘problem’ papers by YN and DJDQuestions are of ‘Mathematical Interest’(number-crunching construction of Year 12 aggregate)(bibliometric measures: ‘impact factors’) Balancing Reduces Asymptotic Variance of OutputsArrivals are Pois